2022 - Op2Lysis

Jérôme Parcq
December 2022
Press Release

The EIC Accelerator grant agreement has been signed by the European Innovation Council and provides €2.5M support to the O2L-001 development programme

The European Innovation Council and SME Executive Agency (EISMA) has validated the EIC Accelerator grant contract and followed the initial recommandation of the independent jury by awarding us the maximum support, i.e. a grant of €2.5M to industrialise O2L-001. The press release:

Bridge Communication
September 2022
Corporate

Orphan drug designation granted to OptPA for the treatment of non-traumatic spontaneous intracerebral hemorrhage by the European Commission

Bridge Communication
April 2022
Corporate

Who are we? Meet Audrey Thiebaut – R&D Project Manager

Through this mini-series of articles, we want to present you our whole team and skills of each. Hello Audrey, could you please introduce yourself? My name is Audrey Thiebaut and I hold a doctorate in the fields of molecular and cellular biology since December 2019. I carried out my thesis, in Caen, in PhIND laboratory […]